CLOs on the Move

Betsy Johnson Regional Hospital

www.bjrh.org

 
Betsy Johnson Regional Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Betsy Johnson Regional Hospital is based in Dunn, NC. You can find more information on Betsy Johnson Regional Hospital at www.bjrh.org
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Medigraphics Corporation

Medigraphics Corporation is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Holmusk

Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Founded in 2015, Holmusk is headquartered in Singapore with offices in North Carolina, New York City, London, Malaysia and Shanghai. Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. Holmusk`s vision is to build the world`s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools. Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine.

Neotonus Inc

Neotonus Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

TRUMPower

TRUMPower is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heart Force Medical

Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.